Calcium-calmodulin-dependent kinase II modulates Kv4.2 channel expression and upregulates neuronal Atype potassium currents by Andrew W Varga et al.
Cellular/Molecular
Calcium–Calmodulin-Dependent Kinase II Modulates Kv4.2
Channel Expression and Upregulates Neuronal A-Type
Potassium Currents
Andrew W. Varga,* Li-Lian Yuan,* Anne E. Anderson, Laura A. Schrader, Gang-Yi Wu, Jennifer R. Gatchel,
Daniel Johnston, and J. David Sweatt
Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030
Calcium– calmodulin-dependent kinase II (CaMKII) has a long history of involvement in synaptic plasticity, yet little focus has been given
to potassium channels as CaMKII targets despite their importance in repolarizing EPSPs and action potentials and regulating neuronal
membrane excitability. We now show that Kv4.2 acts as a substrate for CaMKII in vitro and have identified CaMKII phosphorylation sites
as Ser438 and Ser459. To test whether CaMKII phosphorylation of Kv4.2 affects channel biophysics, we expressed wild-type or mutant
Kv4.2 and the K  channel interacting protein, KChIP3, with or without a constitutively active form of CaMKII in Xenopus oocytes and
measured the voltage dependence of activation and inactivation in each of these conditions. CaMKII phosphorylation had no effect on
channel biophysical properties. However, we found that levels of Kv4.2 protein are increased with CaMKII phosphorylation in transfected
COS cells, an effect attributable to direct channel phosphorylation based on site-directed mutagenesis studies. We also obtained corrob-
orating physiological data showing increased surface A-type channel expression as revealed by increases in peak K current amplitudes
with CaMKII phosphorylation. Furthermore, endogenous A-currents in hippocampal pyramidal neurons were increased in amplitude
after introduction of constitutively active CaMKII, which results in a decrease in neuronal excitability in response to current injections.
Thus CaMKII can directly modulate neuronal excitability by increasing cell-surface expression of A-type K channels.
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Introduction
Calcium– calmodulin-dependent kinase type II (CaMKII) is an
abundant neuronal protein that has received much attention for
its key role in long-term potentiation (LTP), a cellular substrate
for learning. A feature of CaMKII that originally made it an at-
tractive candidate to mediate the synaptic processes underlying
learning is that when CaMKII is activated by a Ca 2– calmodulin
complex, it can be autophosphorylated at Thr286, and this event
renders the kinase autonomously active and less sensitive to ad-
ditional increases in calcium (Hanson et al., 1989). Thus, CaMKII
can translate a transient event (influx of Ca 2) into a long-lasting
change independent of that transient event (autophosphoryla-
tion and enzyme activation).
Moreover, CaMKII has been shown to be necessary and suffi-
cient for LTP induction and necessary for various learning para-
digms (Malenka et al., 1989; Malinow et al., 1989; Silva et al.,
1992a,b; Pettit et al., 1994; Lledo et al., 1995; Wang and Kelly,
1995; Giese et al., 1998; Hinds et al., 1998). Studies assessing the
downstream targets of CaMKII have justifiably focused on gluta-
mate receptor subunits, because they are principally responsible
for excitatory neurotransmission in the CNS and play an impor-
tant role in LTP expression. There are many other potential sub-
strates for CaMKII phosphorylation in the dendritic membrane,
however.
In particular, A-type potassium channels, specifically the
Kv4.2 subunit, are expressed at high density on dendrites of hip-
pocampal pyramidal neurons (Sheng et al., 1992; Maletic-Savatic
et al., 1995; Hoffman et al., 1997). The Shal family of channels, of
which Kv4.2 is a member, comprises four  subunit monomers
that tetramerize to form the channel (Choe et al., 1999). The
Kv4.2  subunit can be modulated by interacting partners in-
cluding Kv  subunits, K channel interacting proteins
(KChIPs), and dipeptidyl peptidase IV-related protein (Nakahira
et al., 1996; Perez-Garcia et al., 1999; An et al., 2000; Holmqvist et
al., 2002; Nadal et al., 2003). Modulation of Kv4.2 is not limited to
protein–protein interactions; Kv4.2 has been shown to be a bona
fide substrate for phosphorylation by extracellular signal-
regulated kinase (ERK)–mitogen-activated protein kinase
(MAPK) and PKA (Adams et al., 2000; Anderson et al., 2000).
These post-translational modifications have been shown to
change both current density and biophysical properties of A-type
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potassium currents thought to be mediated by Kv4.2 (Hoffman
and Johnston, 1998; Yuan et al., 2002). This is significant, because
A-type potassium channels are important for regulating the ex-
citability of neurons, and furthermore, dendritic A-type potas-
sium channels have been implicated in both the induction and
expression of LTP (Watanabe et al., 2002).
Because CaMKII is so crucial to memory formation and be-
cause Kv4.2 seems to be a viable phosphorylation target based on
its function and localization, this study sought to determine
whether Kv4.2 acts as a substrate for CaMKII, and if so, what the
functional consequence of such phosphorylation might be. Here
we present evidence that CaMKII phosphorylates the C terminus
of Kv4.2 at Ser438 and Ser459. These phosphorylation events on
the native channel in the cell result in an increase in total cellular
Kv4.2 assessed biochemically. We obtained corroborating phys-
iological data showing that active CaMKII or CaMKII site aspar-
tate point mutants increased surface A-type channel expression
as revealed by increases in peak K current amplitudes. The
change in peak current amplitude was unaccompanied by
changes in the biophysical parameters of Kv4.2-mediated
A-current. Finally, we demonstrated that constitutively active
CaMKII activity can potentiate native A-currents in hippocam-
pal neurons.
Materials and Methods
Protein expression and purification. The Kv4.2 N-terminal and
C-terminal domain proteins were expressed in Escherichia coli as gluta-
thione S-transferase (GST) fusion proteins using methods modified
from Hakes and Dixon (1992) and Anderson et al. (2000). Plasmids
containing the N-terminal (amino acid residues 1–133) and C-terminal
(amino acid residues 411– 630) domain cDNAs were constructed using
the GST-fusion vector pGEX-KN (Hakes and Dixon, 1992). A single
colony of BL21(DE3)-pLysS cells transformed with the protein plasmid
was grown in Luria broth [LB (170 mM NaCl, pH 7.5, 1% tryptone, and
0.5% yeast extract)] containing 20 g/ml carbenicillin and then used to
seed a 500 ml culture. After growing to an optical density of 0.6 – 0.8
(A600), the culture was centrifuged for 15 min at 1000  g (and 4°C) using
a Beckman Centrifuge Model J2-21M (Beckman Instruments, Fullerton,
CA). The cell pellet was resuspended in 500 ml of LB with carbenicillin.
The bacteria was induced by incubation at room temperature (RT) with
200 M isopropyl -D-thiogalactopyranoside for 4 hr and harvested by
centrifugation.
The cells were resuspended and incubated in Tris buffer 1 (50 mM
Tris-HCl, pH 8.0, 2 mM EDTA, 10 mg/ml pepstatin, 10 g/ml leupeptin,
and 100 M PMSF) containing 10 mM -mercaptoethanol and 100 g/ml
lysozyme (Sigma, St. Louis, MO) for 15 min at 30°C. After solubilization
with 1.5% N-laurylsarcosine, the lysate was incubated with 20 g/ml
DNase I (Boehringer Mannheim, Indianapolis, IN) and 10 mM MgCl2.
The lysate was then centrifuged for 15 min at 1000  g (and 4°C) (RT
6000B; Sorvall, Newtown, CT) and adjusted to a 2% Triton X-100
concentration.
The GST-fusion protein was purified using glutathione affinity ab-
sorption. Glutathione agarose beads were washed, resuspended in Tris
buffer 1, and then incubated with the lysate for 1 hr at 4°C. The beads are
washed three times with Tris buffer 1 by repeated centrifugation (100 
g for 5 min at 4°C; Sorvall). After the final wash, the bead preparation was
resuspended in Tris buffer 2 (20 mM Tris-HCl, pH 7.5, 0.5 mM EDTA, 0.5
mM EGTA, 1 mM Na4P2O7, 10 g/ml aprotinin, and 10 g/ml leupeptin).
Phosphorylation of Kv4.2 N-terminal and C-terminal GST fusion pro-
teins. Kv4.2 N-terminal or C-terminal GST-fusion proteins were incu-
bated at 37°C in reaction mixtures (25 l) containing 70 ng of the cata-
lytic subunit of CaMKII, Tris buffer 2, and ATP mix 1 (100 M ATP, 100
mM MgCl2, and 10 Ci of [-
32P]ATP). Reactions were stopped by
boiling for 5 min with sample buffer (30 mM Tris-HCl, pH 6.8, 200 mM
DTT, 40% glycerol, 8% SDS, and 0.04 mg/ml bromophenol blue). The
GST-fusion proteins were separated by SDS-PAGE (10%) and visualized
by Coomassie blue staining. Phosphopeptides were identified by autora-
diography. As a control, parallel reactions were performed for GST with
and without the kinases and ATP mix 1. A time course of kinase phos-
phorylation was also performed to ensure a maximal extent of
phosphorylation.
Phosphopeptide mapping. Phosphorylation reactions were performed
as described above with some modifications; a preparative scale (reaction
volume of 300 – 400 l) of the reaction was used. The incubation period
was adjusted, based on the time course of kinase phosphorylation of the
fusion proteins. The phosphorylated GST-fusion protein was separated
by SDS-PAGE (10%). After Coomassie blue staining of the gels, the
bands corresponding to the N-terminal or C-terminal fusion proteins
were excised, and an in-gel digestion with trypsin or Lys-C was per-
formed as described previously, with minor modifications (Frangioni
and Neel, 1993; Anderson et al., 2000). After extraction from the gel, the
peptides were separated using reverse-phase HPLC with absorption
monitoring at 214, 254, and 280 nm. Counts per minute in each HPLC
fraction were measured as Cherenkov radiation. Phosphopeptides iden-
tified as HPLC fractions containing high radioactivity were applied to
Sequelon arylamine membranes (Millipore, Bedford, MA) essentially as
described by the manufacturer. After drying, the membrane was rinsed
two times sequentially with 10 ml of methanol, with water, and finally
with 5 ml of 10% trifluoroacetic acid and 50% acetonitrile in water. The
membrane was air-dried, cut into pieces with a scalpel blade, inserted in
a BLOTT cartridge, and sequenced in an Applied Biosystems (Foster
City, CA) model 477A Protein Sequencer with an in-line 120A PTH-
Analyzer using optimized cycles. Instead of butyl chloride, 90% metha-
nol containing phosphoric acid (15 l/100 ml) was used to extract the
cleaved amino acids. After conversion, 50% of the sample was transferred
to the HPLC for PTH-amino acid identification, and the other 50% was
collected in the instrument fraction collector for determination of radio-
activity by scintillation counting.
DNA preparation and site-directed mutagenesis. The original Kv4.2
cDNA was kindly provided by Dr. Paul Pfaffinger (Baylor College of
Medicine, Houston, TX)and subsequently subcloned into a pCI:Neo
vector (Promega, Madison, WI) containing a cytomegalovirus promoter.
Point mutations were made using a site-directed mutagenesis kit (Strat-
agene, La Jolla, CA). The primers used included 5-AGGATACGG-




for S459D. Mutations were confirmed by restriction enzyme digest
and DNA sequencing (Seqwright, Houston, TX). In all cases, the
entire Kv4.2 region was sequenced to determine whether any nonspe-
cific mutations were introduced.
COS-7 and Chinese hamster ovary cell transfection and protein harvest.
The FuGene 6 transfection reagent was used for COS-7 cell transfections
with plasmid DNAs of wild-type or mutant Kv4.2, K  channel interact-
ing proteins (KChIP3), and constitutively active CaMKII or green fluo-
rescent protein (GFP) as a control (1:1:0.2 g ratio). COS-7 cells were
grown on 35 mm plates to a 4  10 5 cell density. Each plate received 3 l
of FuGene 6 reagent and 2 g of total DNA per the FuGene instruction
manual. Eighteen to 30 hr after transfection, COS cells were scraped in 1 ml
of homogenization buffer (HB) per dish (20 mM Tris-HCl, pH 7.5, 1 mM
EGTA, 1 mM EDTA), containing 200 M phenylmethylsulfonyl fluoride, 4
mM para-nitrophenylphosphate, 1 mM sodium orthovanadate, and a 1:100
dilution of protease inhibitor mixture (P-8340; Sigma) [80 M aprotonin,
2.1 mM leupeptin, 104 mM 4-(2-aminoethyl)benzenesulfonyl fluoride, 3.6
mM bestatin, 1.5 mM pepstatin A, and 1.4 mM E-64]. These harvested cells
were then centrifuged at 15,000  g (10,000 rpm in a Hermle Labnet Eppen-
dorf tube centrifuge) at 4°C for 5 min. The supernatant was removed, and
each cell pellet was resuspended in 300 l of HB followed by sonication [10
pulses at output level 1.5 on a Branson (Danbury, CT) Sonifier 250] to lyse
cells. The cell lysate was centrifuged at 60,000 rpm (100,000 g) at 4°C for 20
min in a Beckman ultracentrifuge to isolate cell membranes. The resultant
membrane pellet was suspended in 75 l of 10% SDS containing 100 mM
DTT, 80 ng/ml microcystin, 200 M phenylmethylsulfonyl fluoride, a 1:100
dilution of protease inhibitor mixture (see above), and 25 l of 4 sample
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buffer. Twenty-five microliters of this total 100 l were typically loaded onto
an SDS-PAGE gel.
Surface biotinylation. We followed the protocol of Ehlers (2000).
Briefly, monolayers of COS cells were rinsed with progressively cooler
washes of PBS plus 1 mM MgCl2 and 2.5 mM CaCl2 (PBS 2), followed by
a 20 min incubation with 1.5 mg/ml sulfo-NHS-SS-biotin (Pierce, Rock-
ford, IL) in PBS 2 at 4°C. Unreacted biotin was quenched by rinsing
three times for 5 min with ice-cold 50 mM glycine in PBS 2. Membrane
proteins were harvested as described above except with a 5% rather than
a 10% SDS concentration. This membrane fraction was then incubated
with a 1:1 slurry of BSA-blocked neutravidin beads (Pierce) for 2 hr at
room temperature. The beads were rinsed three times with HB (above)
plus 1% Triton X-100 before proteins were eluted with 1 sample buffer.
Western blotting. Membrane proteins were loaded and run on a 7.5%
acrylamide gel to resolve Kv4.2 and a 10% acrylamide gel to resolve
ERK–MAPK. Gels were then blotted electrophoretically to Immobilon
filter paper using a transfer tank maintained at 4°C, with typical param-
eters being an overnight transfer at a constant current of 250 mA (trans-
fer buffer: 192 mM glycine, 25 mM Tris, pH 8.3). Immobilon filters were
blocked for 1 hr at room temperature in Blotto (10 mM Tris-HCl, pH 7.5,
150 mM NaCl, 0.05% Tween 20, 5% powdered milk, and 0.01% thimer-
osal). All antibody applications were done in Blotto. Primary antibody
concentrations were as follows: 1:500 Kv4.2 polyclonal antibody from
Chemicon (Temecula, CA), 1:2 Kv4.2 monoclonal antibody K57/41.1
from the Trimmer Laboratory (Shibata et al., 2003), and 1:3000 total
ERK from Cell Signaling Technology (Beverly, MA).
Antibody detection. Immobilon filters were incubated sequentially
with primary antibody and a biotin-labeled goat anti-rabbit IgG second-
ary antiserum (1:20,000) and then developed using enhanced chemilu-
minescence (Amersham Biosciences). Blots were washed extensively in
50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05% Tween 20 after incu-
bations with primary and secondary antibodies (typically, four washes of
10 min each).
Functional expression in Xenopus oocytes. Oocytes were harvested from
the ovarian lobe of female Xenopus laevis frogs (Schrader et al., 2002).
Briefly, the frog was anesthetized by submersion in 0.15% tricaine. The
ovarian lobe was then surgically removed and placed in Ca 2-free OR2
solution (in mM: 82.5 NaCl, 2.5 KCl, 1 MgCl2, and 5 HEPES). The frog
was allowed to recover and placed back in the tank. The oocytes were
digested in 1.6 –2.4 mg/ml collagenase (Boehringer Mannheim) for sev-
eral hours. Digested oocytes were then incubated in ND-96 (in mM: 96
NaCl, 2 KCl, 1.8 CaCl2, 1 MgCl2, and 5 HEPES, pH 7.4) supplemented
with pyruvic acid (2.5 mM) and gentamicinsulfate (50 mg/ml; Invitrogen,
San Diego, CA). After 24 hr, oocytes were injected with 16 ng of each
DNA construct using a Nanoject microinjector (Drummond Scientific
Co.) into the nucleus of stage V–stage VI oocytes. Currents were recorded
after 2–3 d under two-electrode voltage-clamp using an Axoclamp 2A
amplifier (Axon Instruments) at room temperature. Microelectrodes
were pulled from filamented glass (1.5  0.86 mm; A-M Systems) filled
with 3 M KCl. The current electrode had resistance of 0.3– 0.5 M,
whereas the voltage electrode ranged from 0.3 to 1 M. Currents were
leak-subtracted on-line using P/4 leak subtraction. Data were digitized at
2 kHz and stored using a Digidata 1200. Current protocols used to obtain
data include activation (hyperpolarization to 110 mV and then depo-
larization to 40 mV for 400 – 800 msec, repeated in 5 mV step inter-
vals) and inactivation (depolarization to 0 mV and then hyperpolariza-
tion to 110 mV for 650 msec, changing this step by 5 mV intervals,
then depolarization to 0 mV). The chamber was continuously perfused
with ND-96 and with NaOH at a rate of 3– 6 ml/min. Data were analyzed
using Clampfit, Origin, and Prism programs. Peak currents were ob-
tained, and conductance was determined using a reversal potential of
95 mV. Activation and inactivation curves were fit with a Boltzman
sigmoidal curve with the following equation: Y  Bottom  (Top 
Bottom)/[1  exp([V1/2  X]/Slope)].
Hippocampal primary culture and transfection. Hippocampal cell cul-
tures were prepared as described previously (Wu et al., 2001). Briefly,
hippocampal CA1–CA3 regions were dissected from 0- to 3-d-old
Sprague Dawley rats, dissociated by trypsin treatment followed by tritu-
ration with a siliconized Pasteur pipette, and then plated onto coverslips
coated with matrigel (1:50). Culture media consisted of minimal essen-
tial media (MEM; Invitrogen), 0.6% glucose, 0.1 gm/l bovine transferrin
(Calbiochem, La Jolla, CA), 0.25 gm/l insulin (Sigma), 0.3 gm/l glu-
tamine, 5–10% fetal calf serum (FCS; Sigma), 2% B-27 supplement (In-
vitrogen), and 2 M cytosine-D-arabinofuranoside (Sigma). Cultures
were maintained at 37°C in a 95% air, 5% CO2-humidified incubator.
The calcium phosphate transfection method (Xia et al., 1996) was used
to transfect the neurons. Briefly, 3–7 d in vitro cell cultures were washed
twice with fresh, serum-free medium (MEM plus 5 gm/l glucose) after
saving original media. Thirty microliters of calcium phosphate precipi-
tate–DNA mixtures were added to each coverslip, and cells were put back
into the incubator for 30 min. After washing twice with serum-free me-
dium, the cells were returned to the incubator after adding back the
original medium.
Electrophysiology. A Zeiss (Oberkochen, Germany) Axioskop, fitted
with a 40 water-immersion objective and differential interference con-
trast, was used to view cultured cells and neurons. Transfected cells and
neurons expressing enhanced GFP (EGFP) were identified under a fluo-
rescent microscope. Whole-cell voltage clamp and outside-out patch
clamp were done in Chinese hamster ovary (CHO)-K1, COS-7, and cul-
tured hippocampal pyramidal neurons using an Axopatch 200 amplifier.
All experiments were performed at RT. For CHO and COS, the bath
solution contained (in mM): 134 NaCl, 2 KCl, 5.6 NaOH, 1.8 CaCl2, 1
MgCl2, and 10 HEPES, pH 7.4. The pipette solution contained (in mM):
140 KCl, 1 MgCl2, 1 EGTA, 0.133 CaCl2, a 10 nM free Ca
2 concentra-
tion, and 10 HEPES, pH 7.4. The K  current reversal potential measured
under this condition was approximately 85 mV. The liquid junctional
potential between pipette solution and bath solution was measured as 7
mV and was not corrected for all experiments.
For pyramidal neurons, the bath solution contained (in mM): 125
NaCl, 2.5 KCl, 25 NaHCO3, 2 CaCl2, 1 MgCl2, and 10 dextrose. The
pipette solution contained (in mM): 120 K-gluconate, 20 KCl, 10 HEPES,
0.2 EGTA, 2 Mg2Cl, 4 Na2ATP, 0.3 Tris–GTP, and 14 phosphocreatine,
pH 7.25 (with KOH). To isolate K  currents in pyramidal neurons, 1 M
TTX and 2 mM MnCl2 were added to the bath to block Na
 currents,
Ca 2 currents, and Ca 2-activated K  currents. To isolate the transient
component (IA), a prepulse protocol (a voltage step to 20 mV for 100
msec before the test pulse) was used, and the difference between the
currents elicited with and without the prepulse was measured. Pipettes
had resistances of between 2 and 5 M. Whole-cell capacitance and
series resistances were compensated to 	80%, and in addition, series
resistances were less than two times the tip resistance. Pulse generation
and data acquisition were controlled with custom software written for
the Igor Pro analysis environment. Leakage and capacitive currents were
digitally subtracted on-line.
Whole-cell current-clamp recordings were made using an Axoclamp
2A (Axon Instruments) amplifier in “bridge” mode at room temperature
and were analog-filtered at 3 kHz. Series resistances were in the range of
10 –15 M. Heteropodatoxin-3 (HpTx-3) (NPS Pharmaceuticals, Salt
Lake City, UT) was dissolved in water and added to the external solution
with 0.1% BSA.
Data analysis. Data were analyzed by using a self-written analysis pro-
gram in Igor. Steady-state activation and steady-state inactivation curves
were constructed and fitted with the normalized Boltzmann equation.
Time course of the recovery from inactivation was fitted with single
exponentials. The current inactivation kinetic was also determined by
single exponential fitting.
Significance ( p 
 0.05) among multiple groups was determined by
ANOVA. A paired or two-sample t test was used when comparisons were
restricted to two means. Error bars represent SEM.
Results
CaMKII phosphorylates the C terminus of Kv4.2 in vitro
To determine whether Kv4.2 is phosphorylated by CaMKII, we
expressed the cytoplasmic N and C termini of Kv4.2 as GST fu-
sion proteins, purified them using affinity chromatography, and
exposed these proteins to 32P-labeled ATP, CaMKII, and the ap-
propriate cofactors in vitro. The proteins were separated via SDS-
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PAGE, and autoradiography revealed 32P
labeling in the C terminus but not in the N
terminus of Kv4.2 (Fig. 1A). GST alone
was not phosphorylated by CaMKII (data
not shown). To determine the phos-
phorylation sites within the C terminus,
we first separated CaMKII-phosphorylated
C-terminal fusion protein via SDS-PAGE
and stained bands with Coomassie blue.
The band representing the C terminus was
excised, eluted, and digested with Lys-C.
We then performed phosphopeptide
mapping and amino acid sequencing of
the phosphorylated Kv4.2 C-terminal fu-
sion protein to directly determine sites of
CaMKII phosphorylation.
Two CaMKII phosphorylation sites
were identified in the C-terminal cytoplas-
mic domain. The phosphopeptide map
for the C-terminal construct demon-
strated three peaks in radioactivity in
HPLC fractions (Fig. 1C) corresponding
to four HPLC absorbance peaks (Fig. 1B).
These HPLC fractions were directly se-
quenced using automated Edman degra-
dation, and the amount of radioactivity
released with each sequencing cycle was
measured (Fig. 1D,E). This revealed two
phosphopeptides: one corresponding to
Kv4.2 C-terminal residues 438 – 444, with
a phosphorylation site at Ser438 (Fig. 1D),
and another corresponding to Kv4.2
C-terminal residues 449 – 468, with a
phosphorylation site at Ser459 (Fig. 1E).
The Kv4.2 sequence from amino acids
432– 445 is RIRAAKSGSANAYM, and the
sequence from amino acids 453– 466 is
LSNQLQSSEDEPAFV. Thus the Ser438
phosphorylation site is more of a prototypi-
cal CaMKII phosphorylation site, contain-
ing an immediately preceding lysine and
several other preceding positive charges.
These data thus implicate CaMKII in Kv4
channel regulation.
CaMKII phosphorylation of Kv4.2 leads to increased total
cellular Kv4.2 protein
Because the above data supported the hypothesis that CaMKII
regulates Kv4.2 through direct phosphorylation, we subsequently
wanted to determine the functional effect of such phosphoryla-
tion. To do so, we used two approaches. One approach entailed
coexpression of Kv4.2 with either of two truncated, constitutively
active forms of CaMKII to test for effects of CaMKII on Kv4.2.
One version of CaMKII was truncated at amino acid 316 (here-
after referred to as CaMKII 316) (Lledo et al., 1995), and the
other is a GFP-labeled, truncated version of CaMKII (hereafter
referred to as tCaMKII) (Hayashi et al., 2000). The second ap-
proach was to use site-directed mutagenesis to test the specificity
of the two CaMKII phosphorylation sites we identified.
We transfected wild-type Kv4.2 plus an accessory subunit
KChIP3 and tCaMKII or GFP into COS-7 cells and harvested
these cells 24 hr after transfection. KChIP3 was included because
it promotes channel synthesis and renders the channel properties
more native-like (An et al., 2000; Schrader et al., 2002). We then
prepared membrane fractions from these cells, separated pro-
teins via SDS-PAGE, and probed for total Kv4.2 protein via West-
ern blotting. When Kv4.2 was cotransfected with tCaMKII, there
appeared to be an approximately fourfold increase in total Kv4.2
protein immunoreactivity (374  70% of control; n  13; p 

0.05) (Fig. 2A–C). To verify that the changes in immunoreactiv-
ity seen with constitutive CaMKII expression were not an artifact
of increased availability of the particular epitope recognized by
the Kv4.2 antibody we used (Chemicon), we demonstrated that
the immunoreactivity to Kv4.2 in the membrane fraction also
increased when a monoclonal antibody recognizing an extracel-
lular epitope of Kv4.2 was applied (Fig. 2D). These data demon-
strate an effect of CaMKII on Kv4.2, specifically a pronounced
increase in protein expression levels.
To ascertain, in part, whether this effect was mediated by the
Kv4.2 phosphorylation sites we had identified, we used site-
directed mutagenesis to convert Ser438 and Ser459 to alanines to
prevent phosphorylation and also converted the sites to aspar-
tates to mimic constitutive phosphorylation. When the S438D–
Figure 1. In vitro phosphorylation of Kv4.2 and identification of CaMKII-phosphorylated residues. A, Purified recombinant GST
fusion proteins expressing the N-terminal (NT) or C-terminal (CT) cytoplasmic domains of Kv4.2 were reacted with CaMKII and the
appropriate cofactors in vitro. Proteins were separated via SDS-PAGE. Left, Coomassie staining of proteins. Right, Autoradiogram
demonstrating 32P incorporation into the C terminus only. B, Phosphopeptide mapping was performed after CaMKII phosphory-
lation of the Kv4.2 GST C-terminal fusion protein. The arrows indicate the absorbance peaks at 214 nm corresponding to the HPLC
fractions with peaks in radioactivity. C, The radioactivity plot illustrates peaks of radioactivity in two different HPLC fractions (one
from fractions 20 –21 and one from fractions 56 –57). 32P counts per minute (CPM) measured as Cherenkov radiation are repre-
sented on the y-axis. D, E, The sequences of the phosphopeptides in HPLC fractions 20 –21 ( D) and fractions 56 –57 ( E) that were
determined by automated amino acid sequencing correspond to amino acids 438 – 444 ( D) and amino acids 449 – 468 ( E) within
the C terminus of Kv4.2. The radioactivity released with each sequencing cycle was measured. There is a peak in sequence cycle 1
for the peptide containing amino acids 438 – 444, indicating that Ser438 is the phosphorylated amino acid in that peptide ( D).
There is a peak in sequence cycle 12 for the peptide containing amino acids 449 – 465, indicating that Ser459 is the phosphorylated
amino acid in that peptide ( E). Phosphorylated residues are marked with an asterisk.
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S459D double-mutant was transfected into COS cells with
KChIP3, the total level of Kv4.2 immunoreactivity mimicked the
increased immunoreactivity on Western blots seen with the co-
transfection of tCaMKII (287  74% of control; n  16; p 
 0.05)
(Fig. 2A,C). This phenotype was unchanged after cotransfection
with tCaMKII (309  82% of control; n  9; p 
 0.05). Con-
versely, when the double-mutant S438A–S459A was introduced
into COS cells, there was a significant reduction in immunoreac-
tivity for Kv4.2 (45  4% of control; n  4; p 
 0.05) (Fig. 2A,B).
When tCaMKII was cotransfected with the double-mutant
S438A–S459A, the total immunoreactivity of Kv4.2 increased,
but not nearly to the extent that the wild-type channel was mod-
ified (169  84% of control; n  4; p 
 0.05). This suggests that
there may be multiple mechanisms by which CaMKII affects
Kv4.2; however, the primary mechanism appears to be via direct
phosphorylation of the C terminus of Kv4.2 at the identified
phosphorylation sites. Overall, these results suggested to us that
CaMKII may be regulating either the net rate of creation or deg-
radation of the Kv4.2 channel; however, we favor the idea of
degradation, because the effects of the apartate point mutants
must of necessity be post-translational.
Because the immunoreactivity of the S438A–S459A double-
mutant was low and sometimes not even detectable, we decided
to ensure that we could accumulate this mutant channel by in-
hibiting its degradation. Therefore, we ap-
plied the proteasome inhibitor MG132 at
20 M for 12 hr. We found that inhibiting
the proteasome in such a manner led to
recovery of protein in the S438A–S459A
Kv4.2 mutant and increased overall chan-
nel protein immunoreactivity in all vari-
ants of Kv4.2 (Fig. 3A). These observa-
tions suggest that Kv4.2 is at least in part
degraded by the proteasome and that
CaMKII may somehow be regulating the
net half-life of the protein in the cell. This
might occur by trafficking the channel to a
stabilized pool or decreasing the rate of
protein breakdown.
It has become increasingly clear that
ubiquitination of proteins is an important
regulatory step in protein degradation and
cycling proteins into and out of cell mem-
branes, particularly for proteins associated
with the postsynaptic density (Ehlers,
2003). Because we had already shown that
Kv4.2 was capable of being regulated by
the proteasome and that CaMKII phos-
phorylation causes cellular accumulation
of Kv4.2, we took particular notice of a
lysine residue at amino acid 437, immedi-
ately preceding one of the CaMKII phos-
phorylation sites at Ser438. We hypothe-
sized that phosphorylation of Ser438
might be blocking access of a ubiquitin li-
gase to Lys437, thereby leading to a stalling
of the degradation process. To test this hy-
pothesis, we used site-directed mutagene-
sis to introduce an alanine at the Lys437
position of Kv4.2. We suspected that the
total Kv4.2-like immunoreactivity of the
K437A mutant of Kv4.2 might be in-
creased in the same way the S438D–S459D
mutant total immunoreactivity is increased in COS cells. How-
ever, the K437A mutant displayed significantly decreased total
immunoreactivity compared with wild-type channel (Fig. 3B).
This result suggests that Lys437 is not involved in Kv4.2 degrada-
tion, and we interpret the decrease in immunoreactivity to rep-
resent an inability of CaMKII to properly recognize the mutant
Kv4.2, thereby resulting in decreased phosphorylation of the
channel. This model is consistent with the known role of up-
stream positively charged residues as being involved in the
CaMKII substrate recognition consensus sequence.
In our Western blotting experiments, we made the serendip-
itous observation that Kv4.2 is often processed into a doublet of
immunoreactivity (Fig. 4B). Thus, we were intrigued by the ob-
servation that inhibiting CaMKII activity pharmacologically with
10 M KN-93 could alter the immunoreactivity of Kv4.2 from a
doublet to a singlet in transfected COS cells (Fig. 4A) along with
decreasing total Kv4.2 protein as expected. The effect on the
CaMKII doublet was first observed when KN-93 was present in
the media 18 hr before harvesting the cells. Previous observations
have suggested that the upper band of immunoreactivity repre-
sents protein specifically trafficked to the cell surface, whereas the
lower band represents a pool of channel that can exist either
intracellularly or at the surface (Shibata et al., 2003). We con-
firmed these previous observations by applying the Golgi traffick-
Figure 2. Changes in immunoreactivity against Kv4.2 by coexpression of constitutively active CaMKII or mutating the identified
CaMKII phosphorylation sites. A, Expression of either the tCaMKII or the 316 constitutively active form of CaMKII (collectively
labeled c.a. CaMKII) instead of GFP, along with Kv4.2 and KChIP3, increased the immunoreactivity against Kv4.2 in the membrane
proteins harvested from transfected COS cells (374  70% of control; n  13; p 
 0.05). CaMKII failed to have as large an effect
on Kv4.2 where both Ser438 and Ser459 have been mutated to alanines (A-double) (169  84% of control; n  4; p 
 0.05). The
A-double-mutant in the absence of constitutively active CaMKII was decreased compared with control (45  4% of control; n 
4; p 
 0.05). Mutagenesis of both Ser438 and Ser459 to aspartates to mimic constitutive phosphorylation (D-double) recapitu-
lated the CaMKII effect (28774% of control; n16; p
0.05). Addition of constitutively active CaMKII to the D-double-mutant
failed to add substantially to the effect of the D-double-mutant in the absence of constitutively active CaMKII (309  82% of
control; n9; *p
0.05). B, Representative Western blot showing the effect of CaMKII activity on Kv4.2 immunoreactivity as well
as the effect of mutating the two CaMKII phosphorylation sites to alanines. C, A separate representative Western blot showing the
effect of introducing aspartates into the two identified CaMKII phosphorylation sites. D, CaMKII phosphorylation does not simply
change the availability of the antibody epitope, because the same phenomenon is observed with a separate monoclonal Kv4.2
antibody. WT, Wild type.
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ing inhibitor Brefeldin A to COS cells transfected with wild-type
Kv4.2 and KChIP3 with or without tCaMKII at the time of trans-
fection. The immunoreactivity of Kv4.2 from cells expressing
either channel alone or channel plus tCaMKII was consistently
restricted to the lower molecular weight band after Brefeldin A
treatment (Fig. 4B), suggesting to us the hypothesis that CaMKII
may be specifically increasing the surface pool of Kv4.2 concur-
rently with increasing total cellular protein.
We therefore tested the hypothesis that CaMKII phosphory-
lation might regulate the extent of cell-surface expression of
Kv4.2 through several independent means. First, we biotinylated
the surface proteins of COS cells expressing Kv4.2 and KChIP3
and either tCaMKII or GFP and then pulled down these biotin-
ylated proteins with neutravidin beads. Cells expressing tCaMKII
displayed increased Kv4.2 in this surface pool compared with
those cells expressing GFP plus Kv4.2 (Fig. 4C). Analysis of the
nonsurface pool of Kv4.2 also showed an increase in immunore-
activity (data not shown), and this finding is consistent with the
hypothesis that CaMKII activity increases both the cell-surface
pool and the total cellular content of Kv4.2. In an additional test
to determine whether CaMKII increases surface Kv4.2 expres-
sion, we took advantage of a C-terminal-directed, PKA-
phosphorylated Kv4.2 antibody that selectively recognizes Kv4.2
expressed at the cell surface (Anderson et al., 2000; Shibata et al.,
2003). Importantly, this phosphoselective antibody does not
nonspecifically cross-react with CaMKII-phosphorylated iso-
forms of Kv4.2 (Anderson et al., 2000). In brief, the antibody is a
phospho-site-specific antibody that recognizes Kv4.2 when it is
phosphorylated by PKA in its C-terminal domain (Anderson et
al., 2000). Shibata et al. (2003), using this antiserum, found that it
selectively recognizes Kv4.2 when it is at the cell surface. The total
immunoreactivity detected with this antibody is greater in COS
cells expressing Kv4.2, KChIP3, and tCaMKII compared with
those expressing Kv4.2, KChIP3, and GFP as a control (Fig. 4D).
This result is consistent with the hypothesis that the Kv4.2 pro-
tein increase that we see is in part attributable to a change in
cell-surface Kv4.2. In addition, the results with this antibody in-
dicate that the increase in Kv4.2 immunoreactivity is not simply
an idiosyncratic effect restricted to the immunoreactivity of a
single antiserum. Together, the simplest explanation of our surface
biotinylation experiments, surface-selective antibody Western blots,
and Brefeldin A experiments is that CaMKII phosphorylation of
Kv4.2 is causing an increase in the surface expression of Kv4.2. In our
next series of studies, we added a physiological correlate to this bio-
chemical evidence by recording surface membrane currents of Kv4.2
expressed in a heterologous cell expression system.
Constitutively active CaMKII potentiates Kv4.2 currents in
transfected COS cells
To address the question of increased surface expression, we de-
cided to measure whole-cell current density in expression sys-
tems. We transfected CaMKII 316 along with wild-type Kv4.2,
KChIP3, and GFP into cultured COS cells. Twenty-four to 48 hr
after transfection, we performed whole-cell patch recordings on
transfected COS cells identified by the GFP marker. The kinetics
of expressed IA shared much similarity with what was reported
Figure 3. Inhibition of the proteasome causes accumulation of Kv4.2. A, To ascertain the
presence of a band in the S4348A–S459A double-mutant of Kv4.2, we applied a 21 M concen-
tration of the proteasome inhibitor MG132 to transfected COS cells for 12 hr. Obvious accumu-
lation of protein in the wild-type (WT) channel, the S438A–S459A double-mutant (A-double),
and the S438D–S459D double-mutant (D-double) was seen with MG132 after harvesting the
cells. B, To test the hypothesis that Lys437, immediately preceding CaMKII phosphorylation site
Ser438, is involved in the ubiquitin-mediated degradation of Kv4.2, we substituted Lys437 for
an alanine. This mutant of Kv4.2 displayed decreased immunoreactivity when cotransfected
with KChIP3 in COS cells compared with the wild-type channel plus KChIP3 (54  4% of control;
n  3; *p 
 0.05). Our interpretation of this result is that Lys437 does not play a role in
ubiquitin-mediated degradation of Kv4.2 but may be necessary as part of the consensus se-
quence for CaMKII recognition of Ser438.
Figure 4. Treatment with KN-93 or Brefeldin A can change the immunoreactivity pattern of
Kv4.2 from a doublet to a singlet. A, Immunoreactivity to Kv4.2 on a Western blot typically
appears as a doublet, and CaMKII seemed to have a specific effect on increasing the immuno-
reactivity of the upper molecular weight species. We applied the CaMKII inhibitor KN-93 at 10
M for various periods of time to COS cells expressing wild-type (WT) Kv4.2 and KChIP3. There
is an obvious decrease in the immunoreactivity of the upper band of Kv4.2, beginning at 18 hr of
KN-93 application. B, There has been previous evidence that this upper molecular weight band
represents a pool of Kv4.2 trafficked to the surface and that the lower molecular weight band
represents an intracellular pool of Kv4.2. To test this more directly, we applied the Golgi traf-
ficking inhibitor Brefeldin A at 10 g/l for 12 hr to COS cells expressing Kv4.2, KChIP3, and
GFP; Kv4.2, KChIP3, and tCaMKII; or the S438D–S459D double-mutant of Kv4.2, KChIP3, and
GFP. We found that such treatment with Brefeldin A changed the immunoreactivity of Kv4.2
from a doublet to a single, lower molecular weight species. This supports the idea that the upper
molecular weight band of Kv4.2 represents a pool of channel trafficked to the surface. C, Isola-
tion of the surface pool of Kv4.2 in COS cells transfected with Kv4.2, KChIP3, and either tCaMKII
or GFP by biotinylation and avidin pulldown reveals that CaMKII phosphorylation can increase
the amount of Kv4.2 at the cell surface. Biotinylation of Kv4.2 causes a change in the electro-
phoretic mobility of the protein such that it runs at 200 kDa. D, CaMKII phosphorylation in-
creases the immunoreactivity of a PKA-phosphorylated, phosphospecific antibody that has
been shown previously to selectively label the cell surface.
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previously for Kv4.2 plus KChIP3 (An et al., 2000; Holmqvist et
al., 2002), and we did not find a dramatic difference in the acti-
vation or inactivation time constant among various experimental
groups (Table 1).
However, the average current density evoked from a step to
20 mV from a 80 mV holding potential was 191.8  23.8
pA/pF (n  13) for the wild-type channel and 422.9  52.4 pA/pF
(n  10) for those cells in which CaMKII 316 was cotransfected,
representing a 	200% increase (Fig. 5A). Again, we were inter-
ested in confirming that this effect was being mediated in part by
direct phosphorylation at the identified sites on the C terminus of
Kv4.2, and we therefore used the phospho-site mutants in this
assay system. The average current density in COS cells expressing
the S438D–S459D double-mutant, when stepped to 20 mV,
was 526.7  70.3 pA/pF (n  10), thus recapitulating the effect of
constitutively active CaMKII on native Kv4.2 currents. Con-
versely, the average current density mediated by the S438A–
S459A double-mutant in CHO cells was 180.8  47 pA/pF (n 
8) when stepped to 20 mV, representing a substantial decrease
compared with the wild-type channel expressed in CHO cells
(wild-type current density at 20 mV, 371.1  26.4 pA/pF; n 
12). CaMKII activity, however, could not potentiate the current
density mediated by this double A-mutant channel, resulting in a
similar current density (217.1  23.1 pA/pF; n  9). These results
indicate a necessity of phosphorylation at these sites for CaMKII
to increase surface expression of Kv4.2 (Fig. 5B). Because we did
not measure single-channel conductance of Kv4.2 or the mean
open time, we cannot rule out a CaMKII effect on these param-
eters; however, the most parsimonious explanation for our find-
ings is that CaMKII phosphorylation of Kv4.2 increases not only
total cellular amounts of Kv4.2 but also a functionally relevant
pool of Kv4.2 protein at the cell-surface plasma membrane, con-
tributing to greater average whole-cell currents. This increase,
however, was not attributable to changes in the voltage depen-
dence of Kv4.2-mediated A-type channels, as shown below.
Kv4.2 channel biophysics are unchanged by
CaMKII phosphorylation
Because phosphorylation events are often multifunctional, we
wondered whether CaMKII phosphorylation altered the channel
biophysical properties of Kv4.2 in addition to increasing the av-
erage peak current amplitude. To assess this, we examined the
voltage-dependent properties of Kv4.2 subunits under various
conditions in COS cells, CHO cells, and Xenopus oocytes. We
found that the voltage dependence of activation and the voltage
dependence of inactivation were unchanged by introduction of
either alanine or aspartate into the 438 and 459 sites or by coex-
pression with constitutively active CaMKII (Fig. 6). All data are
summarized in Table 2. These data suggest that CaMKII does not
regulate the voltage dependence of activation or inactivation of
Kv4.2. These data also serve as an important control, demonstrat-
ing that the mutant channels are functionally, and thus most
likely structurally, indistinguishable from native Kv4.2 in their
basic properties. In other words, the decrease in Kv4.2 current
expression with the serine-to-alanine mutants is not attributable
to rendering the channel incapable of conducting potassium ions
or detecting changes in membrane potential.
CaMKII potentiates A-type currents in hippocampal
pyramidal neurons
There is evidence to suggest that Kv4.2 underlies the A-type K
current in the somata and dendrites of hippocampal pyramidal





Wild type (n  10) 3.2  0.3 58.2  3.1
Wild type plus CaMKII 316 (n  7) 3.8  0.4 61.3  5.5
S438D–S459D (n  8) 4.0  0.7 60.8  4.5
Wild type (n  8 –11) 3.0  0.2 53.2  2.6
S438A–S459A (n  6) 3.4  0.3 58.2  5.1
S438A–S459A plus CaMKII 316 (n  9) 3.1  0.2 52.0  3.4
Above measurements were from currents elicited by a voltage step to 0 mV (Vh  80 mV). Multigroup compar-
isons within two groups showed no significant difference (ANOVA; p 	 0.05).
Figure 5. CaMKII activity can increase the peak current amplitude of Kv4.2 currents ex-
pressed in a heterologous system. A, We recorded the whole-cell current responses to a family of
voltage steps in COS cells expressing wild-type (wt) Kv4.2, KChIP3, and either GFP (wild type) or
constitutively active CaMKII (316). The peak current amplitude of cells expressing constitu-
tively active CaMKII was significantly greater than control (191.8  23.8 pA/pF, n  13, for the
wild-type channel; 422.9  52.4 pA/pF, n  10, for a voltage step to 20 mV from a 80 mV
holding potential) for cells cotransfected with constitutively active CaMKII. Similarly, the
S438D–S459D double-mutant (D-double) plus KChIP3 and GFP displayed significantly in-
creased peak current amplitudes compared with the wild-type channel (526.7  70.3 pA/pF,
n  10, for the same voltage step). ***p 
 0.005; ANOVA. Asterisks within bars indicate a
significant change compared with control. n.s., Not significant. B, Expression of the S438A–
S459A double-mutant (A-double) plus KChIP3 and GFP in CHO cells resulted in significantly
decreased peak current amplitudes in response to a family of voltage steps compared with the
wild-type channel plus KChIP3 and GFP (wt) (371.1  26.4 pA/pF, n  12, for wt; 180.8  47
pA/pF, n 8, for S438A–S549A). This reduction in peak current amplitude could not be rescued
by addition of constitutively active CaMKII, demonstrating the specificity of the sites (217.1 
23.1 pA/pF; n  9 for S438A–S459A plus KChIP3 and constitutively active CaMKII). *** p 

0.005; ANOVA. Asterisks within bars indicate a significant change compared with control. n.s.,
Not significant.
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neurons (Serodio and Rudy, 1998; Song et al., 1998; Tkatch et al.,
2000). Because we observed a CaMKII-mediated increase in
Kv4.2 currents expressed in a heterologous expression system, we
decided to test whether CaMKII could also regulate native A-type
current in neurons. To this end, we transfected tCaMKII and GFP
into dissociated cultured hippocampal neurons. We used CA1–
CA3-enriched primary cultures, including CA1 pyramidal neu-
rons, CA3 pyramidal neurons, and various types of interneurons.
To avoid variations in native IA density and to reduce the com-
plexity of the molecular identity of native IA among different cell
types, we chose to restrict our studies to responses from pre-
sumed CA1 pyramidal neurons. Our criteria for a CA1 pyramidal
neuron included the presence of a major apical dendrite, some
basal dendrites, and a relatively small soma that had whole-cell
capacitance of 
20 pF (Fig. 7A). Twenty-four to 48 hr after trans-
fection, we recorded whole-cell K currents from expressing
neurons, and the transient A-current component was isolated by
a prepulse voltage protocol (Fig. 7B). Most recordings were ob-
tained from GFP control and tCaMKII–GFP fusion construct-
expressing neurons with similar shapes and sizes. In addition to
Kv4 subunits, Kv1.4 subunits were also expressed in hippocam-
pal pyramidal neurons (Veh et al., 1995; Grosse et al., 2000); thus
they may also underlie the native IA of CA1 pyramidal neurons. It
was reported that CaMKII activity also regulates Kv1.4-mediated
currents in an expression system (Roeper et al., 1997). One of the
aspects of regulation was that the channel inactivation was dra-
matically slowed by CaMKII activity, resulting in a larger time
constant () of current decay. Under our experimental condition,
when GFP neurons were held at 80 mV and stepped to 0 mV,
the averaged  was 24.5  1.7 msec. To avoid the contribution
from Kv1.4 subunits in the native IA amplitude upregulated by
CaMKII, we focused our studies on these tCaMKII-expressing
neurons with a current decay  that was not larger than 35 msec.
The mean  of these tCaMKII neurons was 29.2  2.2 msec and is
not statistically different from that of GFP control ( p 	 0.1). The
peak A-current amplitude obtained from a step to 0 mV from a
holding potential of 80 mV in tCaMKII-expressing neurons
was significantly greater than the current density obtained in
control neurons (624.1  79.2 pA, n  11 for control neurons vs
1162.3  67.2 pA, n  14 in tCaMKII expressing neurons) (Fig.
7C). Although it was observed that the somata of tCaMKII neu-
rons tended to be somewhat round in shape compared with that
of GFP control, the difference in whole-cell capacitance (an indi-
cator of cell size) was not statistically significant ( p 	 0.5) be-
tween tCaMKII neurons and GFP control. As a result, the current
density of tCaMKII neurons (78.8  4.9 pA/pF) was significantly
larger than control (38.7  3 pA/pF; p 
 0.001) (Fig. 7D). These
results demonstrate that CaMKII has the ability to upregulate the
amplitude of somatodendritic A-type currents in hippocampal
neurons. Thus, the effect of CaMKII on Kv4.2-encoded
A-currents is likely not limited to heterologous systems, but also
occurs in native neurons expressing endogenous A-type
channels.
Constitutive CaMKII expression alters hippocampal neuronal
firing properties
Because the A-type K current (IA) is important for regulating
neuronal excitability and the repetitive firing of neurons, we hy-
pothesized that the CaMKII-mediated increase in neuronal
A-currents might affect the firing properties of hippocampal py-
ramidal neurons. We compared the responses of control hip-
pocampal pyramidal neurons and neurons that had been trans-
fected with constitutively active CaMKII. As described above,
recordings were obtained from GFP- and tCaMKII-expressing
neurons with similar shapes and sizes. First, the resting mem-
brane potential (Vm) of tCaMKII neurons was more depolarized
than that of GFP control cells (59.7  1.5 vs 68.3  3.1 mV; n 
7; p 
 0.05) (Fig. 8C). Second, tCaMKII caused a small but sta-
tistically significant increase in threshold current (21.7  3 pA;
n  7) compared with GFP-expressing neurons (13.5  1.3 pA;
Table 2. Voltage-dependent properties of various Kv4.2-encoded K currents
Activation Inactivation
V1/2 (mV) Rate V1/2 (mV) Rate
COS
Wild type (n  5) 6.1  3.5 22.5  0.8 70.3  2.3 8.2  1.1
Wild type plus CaMKII 316 (n  4) 13.7  2.7 21.8  1.4 68.3  1.7 5.3  0.5
S438D–S459D (n  4) 8.4  2.6 21.2  1.7 68.7  2.1 5.8  1.5
CHO
Wild type (n  4) 1.4  2.9 21.9  0.7 60  1.8 4.1  0.3
S438A–S459A (n  4) 7.8  2 20.5  1.3 63.5  0.7 7.1  0.2
S438A–S459A plus CaMKII 316 (n  5) 4  3 21.7  0.3 59.5  1.7 4.6  0.4
Oocytes
Wild-type (n  4) 18.0  2 15.3  0.4 60.3  0.9 3.5  0.1
S438A–S459A (n  10) 18.6  0.8 15.2  0.3 61.6  0.9 3.5  0.1
S438D–S459D (n  9) 17.4  0.9 15.4  0.5 64.1  1.4 3.5  0.1
Wild type plus CaMKII 316 (n  16) 21.2  1 15.2  0.1 67.2  0.6 3.6  0.1
Multigroup comparisons for each parameter within three groups showed no significant difference (ANOVA; p 	 0.05).
Figure 6. CaMKII does not affect the biophysical properties of the Kv4.2 channel. To assess
whether CaMKII could affect the biophysical properties of the Kv4.2 channel, we expressed
Kv4.2, KChIP3, and GFP in Xenopus oocytes and used a two-electrode voltage clamp to perform
activation and inactivation protocols. Neither constitutively active CaMKII (316) expression
nor substitution of the CaMKII phosphorylation sites with alanines (A-double-mutant) or aspar-
tates (D-double-mutant) affected the voltage dependence of activation or inactivation. WT,
Wild type.
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n  7; p 
 0.05) when Vm was held at 70 mV. Third, in
response to a 1.5–2 times threshold current for 700 msec, the
control neurons fired rhythmically without a decrease or with
only a slight decrease in amplitude of subsequent action poten-
tials (Fig. 8A). tCaMKII-expressing neurons, however, exhibited
a disrupted firing pattern. To quantify the change in firing pat-
tern, we measured the delay to the first action potential in re-
sponse to a 700 msec current injection. CaMKII-expressing neu-
rons showed a significantly prolonged onset to fire the first AP
(403.6  31.3 pA; n  7) compared with GFP controls (230.1 
19.3 pA; p 
 0.001) (Fig. 8A,C). To test the contribution of Kv4
subunits to the prolonged onset observed in tCaMKII neurons,
we used HpTx-3, a spider toxin shown to be specific for Kv4
subunits (Sanguinetti et al., 1997; Ramakers and Storm, 2002). As
shown in Figure 8, when the injected currents were kept the same,
the prolonged onset for APs in tCaMKII neurons was reversely
shortened by application of 50 –100 nM HpTx-3 from 405  19.2
to 117.4  11.9 msec (n  4; p 
 0.01) (Fig. 8B,C). These data are
consistent with our hypothesis of CaMKII increasing neuronal
cell-surface Kv4 family potassium channels. Although we cannot
rule out the possibility of CaMKII affecting other conductances
(for example, those that contribute to the resting membrane po-
tential), it is worth noting that neurons selectively overexpressing
only Kv4.2 subunits, resulting in a subsequent increase in IA den-
sity, display firing properties similar to what we observed in
tCaMKII-transfected neurons (Shibata et al., 2000). This obser-
vation supports the hypothesis that the changes in firing proper-
ties seen with introduction of constitutively active CaMKII are
mediated via increases in A-type K currents.
Discussion
Our findings support the idea that
CaMKII regulates a novel target, the
voltage-gated potassium channel Kv4.2,
and that this interaction has the functional
consequence of increasing channel ex-
pression and decreasing neuronal excit-
ability. We began with a biochemical ap-
proach, identifying the cytoplasmic C
terminus of Kv4.2 as the major site of
phosphorylation and, using phosphopep-
tide mapping and direct amino acid se-
quencing, found Ser438 and Ser459 as
specific phosphorylation sites. We dem-
onstrated that CaMKII phosphorylation
of Kv4.2 results in increased total cellular
Kv4.2 protein, but it was unclear to us
whether this also resulted in an increase in
functional channels at the cell surface or
whether the channel was merely trapped
in an intracellular membrane such as the
endoplasmic reticulum, Golgi body, or
endosomes. Using a surface biotinylation
approach and by recording whole-cell
A-currents from COS cells transfected
with Kv4.2 and constitutively active
CaMKII, we demonstrated that a signifi-
cantly increased fraction of Kv4.2 reaches
the cell surface when CaMKII is present,
resulting in increased peak Kv4.2 currents.
This increase in peak current amplitude
was unaccompanied by changes in the
voltage dependence of activation and in-
activation of Kv4.2. We also demonstrated
that CaMKII not only potentiates Kv4.2 currents in a heterolo-
gous expression system but also increases the peak amplitudes of
endogenous A-type currents in hippocampal neurons. Finally,
we found that introduction of constitutively active CaMKII into
hippocampal neurons causes a change in neuronal firing patterns
such that the neuron has a smaller probability of firing an action
potential in response to a given current input, and that the onset
of action potentials is significantly delayed.
Our finding that constitutively active CaMKII leads to de-
creased neuronal excitability is consistent with several other stud-
ies suggesting a role for CaMKII in altering neuronal excitability.
Neurons from mutant Drosophila expressing a CaMKII inhibi-
tory peptide display increased spike frequency, increased action
potential duration, and decreased stability of spike frequency
coding, hallmarks of increased neuronal excitability (Yao and
Wu, 2001). Interestingly, these neurons also display a significant
decrease in A-type potassium current density. Mice with a null
mutation for -CaMKII have increased neuronal excitability and
display both spontaneous seizures and a decreased threshold for
evoked seizures that involve the hippocampus (Butler et al.,
1995). Similarly, CaMKII inhibition in cultured rat hippocampal
neurons through an antisense oligonucleotide resulted in in-
creased spike frequency and epileptiform activity (Churn et al.,
2000). Prolonged application of the CaMKII inhibitor KN-62 to
cultured embryonic mouse hippocampal neurons caused a sig-
nificant decrease in A-type currents with a concomitant decrease
in whole-cell capacitance, and it was suggested that this resulted
from decreased CaMKII-mediated fusion of channel-bearing
Figure 7. Active CaMKII increased A-type K  current in cultured hippocampal neurons. A, Fluorescence image of an EGFP-
transfected CA1 pyramidal neuron (arrow). B, Schematic diagram of the prepulse voltage protocol used to isolate native A currents.
The prepulse was to 40 or 20 mV. C, Representative A currents obtained from a control pyramidal neuron expressing EGFP
(top) and a similar-sized pyramidal neuron expressing tCaMKII (bottom). Neurons were held at 80 mV and stepped to 0 mV.
Decay of the A currents was fit with a single exponential. CaMKII activity increased the transient A-type K  current amplitude
without a change in the inactivation time constant. D, Summary data for whole-cell capacitance, peak current at 0 mV, current
density, and inactivation time constant for EGFP (E) and tCaMKII (C) transfected neurons. (***p 
 0.001).
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vesicles with the plasmalemma (Wu et al., 1998). Clearly, from
these studies and our own, CaMKII activity is required for main-
taining normal cellular excitability in many systems.
Our results are distinct from accounts of CaMKII regulation
of A-type currents in non-neuronal cell types as well as data sug-
gesting a role for CaMKII in regulating the biophysical properties
of other molecular mediators of A-type currents. For example, in
murine colonic myocytes, inhibition of CaMKII with KN-93 or
KN-62 causes an increased rate of A-type channel inactivation
and slows the recovery from inactivation with no change in peak
current amplitude (Koh et al., 1999). In human atrial myocytes,
KN-93 also accelerates the inactivation of the transient outward
potassium current (Ito), and in this case the amplitude of the
maintained component is also decreased (Tessier et al., 1999).
Thus, CaMKII seems to have similar effects on Kv1.4, which also
mediates an A-type current. In this vein, increasing CaMKII ac-
tivity in human embryonic kidney cells expressing Kv1.4 caused a
slowing of inactivation and accelerated recovery from inactiva-
tion of Kv1.4 currents (Roeper et al., 1997). Overall, the trend for
CaMKII modulation of A-type currents outside the brain or en-
coded by non-Kv4 molecular species has been one of altering
channel biophysics, whereas CaMKII modulation of neuronal
Kv4.2 increases the current amplitude. However, in all cases,
CaMKII activity ultimately increases the availability of the under-
lying A-type channel.
Our studies do not identify the precise molecular mechanisms
by which CaMKII increases Kv4.2 surface expression levels. One
possibility is that CaMKII is increasing surface expression via
mass action, by increasing protein half-life and increasing total
cellular Kv4.2 protein. This potential mechanism is in contrast to
CaMKII specifically trafficking Kv4.2 to the cell surface via
phosphorylation-dependent mechanisms. Which of these is the
most likely mechanism is particularly hard to ascertain, because
these two possibilities are not mutually exclusive. In addition,
surface membrane insertion is known to be able to stabilize pro-
teins and increase their half-life. Thus, increased surface traffick-
ing could result in a secondary increase in total protein in the cell.
Alternatively, as mentioned above, simply increasing half-life can
increase total protein and drive protein into the surface mem-
brane. At present, each of these remains a viable alternative based
on our observations.
Our findings are surprising, in that CaMKII phosphorylation
of Kv4.2 and the resulting alteration in A-type current has the
opposite effect of several other major kinases implicated in learn-
ing. For example, it has already been demonstrated that PKA and
PKC shift the activation curve for A-type channels 15 mV in the
depolarizing direction in the distal dendrites of CA1 pyramidal
neurons, a net inhibition of channel function (Hoffman and
Johnston, 1998). Application of inhibitors of mitogen- and extra-
cellular signal-regulated kinase (MEK), an upstream activator of
ERK, to hippocampal pyramidal neurons results in an increased
availability of A-type K channels, indicating that ERK inhibits
A-type channel function (Watanabe et al., 2002). Similarly, stim-
ulation of -adrenergic receptors in hippocampal slices via iso-
proterenol application boosts backpropagating action potential
amplitude in a PKA- and ERK–MAPK-dependent manner (Yuan
et al., 2002), a finding consistent with ERK inhibition of A-type
channels. Furthermore, PKC suppresses Kv4.2 currents in Xeno-
pus oocytes (Nakamura et al., 1997), and glial-derived neurotro-
phic factor application to dopaminergic neurons, acting through
the ERK–MAPK pathway, suppresses A-type channels, leading to
increased neuronal excitability (Yang et al., 2001). Thus PKA,
PKC, and ERK–MAPK phosphorylation of Kv4.2 appear to result
in suppression of the channel, leading to increased excitability,
whereas CaMKII phosphorylation enhances channel activity
through increasing surface expression. This dichotomy was the
opposite of our expectation entering into these studies.
Given the multifaceted role of CaMKII in synaptic plasticity,
one may wonder how a neuron might use a CaMKII-mediated
upregulation of A-type current in this context. Because CaMKII
has been shown to be involved in synaptic potentiation, one pos-
sibility is that CaMKII-mediated increases in Kv4.2 channel den-
sity constitute a negative feedback response, affecting the ability
of synapses to undergo subsequent potentiation. Thus, CaMKII
regulation of Kv4.2 insertion might be one specific mechanism
contributing to a sliding threshold for LTP/long-term depression
induction.
A related idea is that CaMKII-mediated upregulation of Kv4.2
could be involved in maintaining the homeostasis of neuronal
firing properties (Marder and Prinz, 2002). In support of the
homeostasis hypothesis, it has been demonstrated in the crab
stomatogastric ganglion that several hours of depolarizing cur-
Figure 8. Active CaMKII changed the basic firing properties of hippocampal neurons. A,
Representative traces of the action potential firing pattern of an EGFP-expressing (left) and a
tCaMKII-expressing (right) pyramidal neuron in response to current injections. The amplitude of
the injected current was 1.5–2 times threshold. Constitutively active CaMKII (tCaMKII) in-
creased the time to fire the first AP under similar conditions. B, The prolonged onset to fire the
first AP observed in the tCaMKII-expressing neuron (left) could be reversed by application of
50 –100 nM HpTx-3 (right). C, Summary data for resting membrane potential, current threshold
to fire APs, and delay to fire the first AP before and after HpTx-3 are shown for EGFP-expressing
(E) and CaMKII-expressing (C) neurons (*p 
 0.05; ***p 
 0.001).
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rent pulses lead to increased peak current amplitudes of A-type
potassium current (Golowasch et al., 1999). These increases were
reversible after cessation of activity and were also inhibited by
blocking calcium entry into cells. Our results offer a mechanism
by which such homeostasis may occur: CaMKII activity can act as
a readout of average Ca 2 influx and directly phosphorylate the
C terminus of Kv4.2. In turn, this results in an increase in average
A-currents that dampens the response of the neuron to the in-
creased activity, until equilibrium is reached.
Finally, it has been demonstrated both electrophysiologically
(Hoffman et al., 1997; Yuan et al., 2002) and anatomically (Varga
et al., 2000) that there exists a gradient of A-type current and the
underlying Kv4.2  subunit, respectively, along hippocampal
dendrites with increasing concentration away from the soma.
However, the mechanisms establishing and maintaining this gra-
dient are poorly understood. CaMKII-mediated upregulation of
Kv4.2 offers a plausible mechanism for maintaining this gradient,
especially in that there exists a gradient of synaptic activity along
a dendrite, which could lead to a gradient of average Ca 2 influx
and CaMKII activity.
Numerous long-term changes in synaptic responses and
membrane excitability have been implicated in LTP. The nature
of and mechanisms underlying the synaptic conductance change
have been extensively investigated. In particular, increased syn-
aptic activity involving CaMKII drives glutamate receptors into
synapses to potentiate synaptic responses (Hayashi et al., 2000)
and also leads to increased current flux through the channel (Bar-
ria et al., 1997; Derkach et al., 1999; Poncer et al., 2002).
However, there are often changes in excitability and EPSP–
spike coupling associated with neuronal plasticity, the mecha-
nisms of which remain unknown. From the results of this study,
we propose that one mechanism by which CaMKII activity may
influence neuronal excitability is via regulation of potassium
channels. Specifically, we propose that CaMKII phosphorylation
of Kv4.2 subunits that mediate dendritic IK(A) promotes surface
insertion of the channel in cells. These studies are particularly
exciting in that they are the first to suggest a precise molecular
mechanism underlying activity-dependent long-term modifica-
tion of dendritic function per se. The implication of these studies
is more general, in that K channels can be applied as an addi-
tional site beyond synaptic AMPA receptors for the regulation of
ion channels by protein kinases during LTP. Together with the
potentiation of synaptic conductances provided by AMPA recep-
tor insertion, CaMKII-mediated insertion of Kv4.2 channels may
provide a new dimension of plasticity that shapes the integrative
properties of neurons and extends the computational capacity of
neuronal networks.
In conclusion, our data have identified Kv4.2 as a novel target
for CaMKII regulation with effects on channel surface expression
and peak current amplitudes that are specific to the identified
sites of phosphorylation on the C terminus of Kv4.2. CaMKII-
mediated increases in peak A-current amplitude have strong ef-
fects on dampening neuronal excitability in hippocampal neu-
rons. Our findings provide a mechanism by which changes in
CaMKII activity can alter neuronal excitability and also offer a
plausible mechanism underlying homeostatic neuronal plastic-
ity. These results offer a framework with which to address future
questions about not only the mechanisms behind CaMKII-
mediated increased surface expression of Kv4.2 channels but also
the consequences of calcium-triggered changes in channel ex-
pression in a time-specific and location-specific manner.
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